Literature DB >> 28095910

Profile of bioactive compounds in Nymphaea alba L. leaves growing in Egypt: hepatoprotective, antioxidant and anti-inflammatory activity.

Riham Omar Bakr1, Mona Mohamed El-Naa2, Soumaya Saad Zaghloul3, Mahmoud Mohamed Omar4,5.   

Abstract

BACKGROUND: Nymphaea alba L. represents an interesting field of study. Flowers have antioxidant and hepatoprotective effects, rhizomes constituents showed cytotoxic activity against liver cell carcinoma, while several Nymphaea species have been reported for their hepatoprotective effects. Leaves of N. alba have not been studied before. Therefore, in this study, in-depth characterization of the leaf phytoconstituents as well as its antioxidant and hepatoprotective activities have been performed where N. alba leaf extract was evaluated as a possible therapeutic alternative in hepatic disorders.
METHODS: The aqueous ethanolic extract (AEE, 70%) was investigated for its polyphenolic content identified by high-resolution electrospray ionisation mass spectrometry (HRESI-MS/MS), while the petroleum ether fraction was saponified, and the lipid profile was analysed using gas liquid chromatography (GLC) analysis and compared with reference standards. The hepatoprotective activity of two doses of the extract (100 and 200 mg/kg; P.O.) for 5 days was evaluated against CCl4-induced hepatotoxicity in male Wistar albino rats, in comparison with silymarin. Liver function tests; aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma glutamyl transpeptidase (GGT) and total bilirubin were performed. Oxidative stress parameters; malondialdehyde (MDA), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), total antioxidant capacity (TAC) as well as inflammatory mediator; tumour necrosis factor (TNF)-α were detected in the liver homogenate. Histopathological examination of the liver and immunohistochemical staining of caspase-3 were performed
RESULTS: Fifty-three compounds were tentatively identified for the first time in N.alba leaf extract, where ellagitannins represent the main identified constituents. Nine hydrocarbons, two sterols and eleven fatty acids were identified in the petroleum ether extract where, palmitic acid and linolenic acids represented the major saturated and unsaturated fatty acid respectively. N.alba AEE significantly improved the liver function, oxidative stress parameters as well as TNF-α in addition to the amelioration of histopathological features of the liver and a profound decrease in caspase-3 expression.
CONCLUSION: These results shed light on the hepatoprotective effect of N. alba that is comparable with that of silymarin. The antioxidant activities of N. alba extract in addition to the inhibition of crucial inflammatory mediator, as TNF-α, might be the possible hepatoprotective mechanisms.

Entities:  

Keywords:  Ellagitannins; Hepatotoxicity; Inflammation; Nymphaea alba; Oxidative stress; Palmitic acid

Mesh:

Substances:

Year:  2017        PMID: 28095910      PMCID: PMC5240310          DOI: 10.1186/s12906-017-1561-2

Source DB:  PubMed          Journal:  BMC Complement Altern Med        ISSN: 1472-6882            Impact factor:   3.659


Background

Hepatotoxicity is a prevalent problem worldwide. Carbon tetrachloride (CCl4) is a chlorinated hydrocarbon that is commonly used in industries as a solvent and in medicine as a vermifuge. The compound is also found at low levels in ambient air and water [1]. Exposure to CCl4 is known to result in acute hepatotoxicity in humans and experimental animals. It is widely used in scientific research as a model of hepatotoxicity and to evaluate hepatoprotective agents [2, 3]. CCl4 is converted by cytochrome P450 2E1 to trichloromethyl free radical (CCl3∙) and trichloromethylperoxy radical (CCl3OO∙). Both radicals initiate lipid peroxidation and protein deterioration with subsequent damage of the cellular membrane and leakage of intracellular enzymes into the serum. These processes eventually lead to inactivation of the calcium pump with calcium influx and subsequent liver cell death. Moreover, lipid peroxidation and damage of hepatocyte membranes initiated by CCl4 was reported to be associated with the release of inflammatory mediators such as tumour necrosis factor (TNF)-α from activated hepatic macrophages, which potentiate CCl4-induced hepatic injury [3, 4]. Nymphaea alba L. (N. alba), known as the European water lily, White Lotus, or Nenuphar, is an aquatic flowering plant of the family Nymphaeaceae. N. alba was widely used in Indian folk medicinal products as an antiseptic, an astringent, radical scavenger, in burning and in insomnia while rhizomes are applied externally as a rubefacient [5]. Previously published studies reported the antioxidant, anti-inflammatory as well as hepatoprotective effect of N. alba flowers [6-8]. These effects may result from the phenolic constituents, including ellagic and gallic acid and their methyl and ethyl esters and flavonoids as aglycones of quercetin, kaempferol, isokaempferide, apigenin and their glycosides previously identified in the flowers [9, 10]. A recent study on the rhizomes revealed the presence of hydrolysable tannins, glycosylated phenolic acids and flavonoids. The methyl and ethyl gallate as well as pentagalloyl glucose, the main constituents identified, showed powerful cytotoxic activity against liver cell carcinoma [11]. Leaves of the white flowered water lily have been evaluated for their cytotoxic, antiproliferative and anxiolytic activities [12-14]. The broad range of traditional uses along with the previous reports concerning the hepatoprotective effect of N. alba flowers [7] as well as other Nymphaea species [15], and the absence of any reports about the phytochemical profile of N. alba leaf, aroused our interest in N. alba as a source of bioactive compounds. This study represents the first detailed chemical investigation of N. alba leaf that demonstrates the presence of a variety of free and conjugated forms of ellagic acid and ellagitannins tentatively identified by high-resolution electrospray ionisation mass spectrometry (HRESI-MS/MS) in the aqueous ethanolic extract. Hepatoprotective, antioxidant and anti-inflammatory activity of the N. alba leaf extract against CCl4- induced hepatotoxicity have also been studied and showed promising results.

Methods

Plant material

Leaves of N. alba L. were collected from El Orman Gardens, Giza, Egypt, in November, 2013 during the flowering stage. Authentication of the plant was performed by Dr. Therese Labib Youssef (consultant in plant taxonomy, Ministry of Agriculture). A voucher specimen (RS006) is deposited at the herbarium of the Pharmacognosy Department, Faculty of Pharmacy, October University for Modern Science and Arts, Egypt.

Extraction

The powdered air-dried leaves of N. alba (300 g) were exhaustively extracted with aqueous ethanol (70% v/v) under reflux. After filtration, the aqueous ethanolic extract (AEE) was evaporated to dryness in vacuum at 40 °C to yield 33 g.

Liquid chromatography coupled with High-resolution electrospray ionisation mass spectrometry (LC-HRESI-MS/MS)

LC-HRESI-MS/MS was performed on a Bruker Micro-TOF-Q Daltonics (API) Time-of-Flight mass spectrometer (Bremen, Germany), coupled to a 1200 series HPLC system (Agilent Technologies, Waldbronn, Germany), equipped with a high performance autosampler, binary pump, and PDA detector G 1314 C (SL). Chromatographic separation was performed on a Superspher 100 RP-18 (75 × 4 mm i.d.; 4 m) column (Merck, Darmstadt, Germany).

Identification of Phenolic Compounds of AEE of N. alba by LC-HRESI-MS/MS

The method was performed according to Hassaan et al. [16]. Injection volume was 10 L. The solvents were: (A) 2% acetic acid (pH 2.6) and (B) 80% methanol, 2% acetic acid, and pH 2.6. The gradient elution was from 5 to 50% B at 30 °C at a flow rate of 100 L/min. The ionization technique was an ion spray (pneumatically assisted electrospray). Spectra were recorded in positive and negative ion modes between m/z 120 and 1,500 with capillary voltage, 4000 V and heated dry nitrogen gas (temperature, 200 °C) and flow rate 10 L/min. The gas flow to the nebulizer was set at pressure 1.6 bar. For collision-induced dissociation (CID) MS/MS measurements, the voltage over the collision cell varied from 20 to 70 eV. Argon was used as the collision gas. Data analysis software was used for data interpretation. Sodium formate was used for calibration at the end of the LC/MS run. Interpretation for ESI-MS was performed by Xcalibur 2.2 SP1 software from Thermo Scientific (Berlin, Germany).

Gas Liquid Chromatography (GLC) of Unsaponifiable Matter (USM) and Fatty Acid Methyl Ester (FAME)

Powdered air-dried leaves (100 g) were exhaustively extracted with petroleum ether (60–80 °C). The petroleum ether extract was filtered and evaporated under reduced pressure. The petroleum ether extract (1 g) was saponified by refluxing with ethanolic KOH (20%) at 60 °C for 2 h and then exhaustively extracted with ether. The combined ethereal extracts were washed, dehydrated over anhydrous sodium sulphate, evaporated to dryness and then analysed as unsaponifiable matter (USM) for the hydrocarbon and sterol contents. The saponified extract was acidified with HCl (5 N) and then extracted several times with ether. The combined ethereal extracts were evaporated to dryness, esterified into fatty acid methyl esters (FAMEs) by reflux with MeOH:H2SO4 (50:3) and extracted with ether [17]. The ether extracts of the USM and FAME fractions were analysed by GLC against the available authentic standards. Identification of hydrocarbons, sterols, and fatty acid methyl esters was carried out by comparing retention times of the peaks with those of the available authentic standards. FAMEs were analysed on a 70% Thermo Scientific Trace TR-FAME gas chromatographic (GC) capillary column packed with 70% Cyanopropyl Polysilphenylene-siloxane, 30 m x 0.25 mm id. The injector and detector temperatures were set at 250 and 300 °C, respectively. The temperature was increased 70 ° C to 190 °C at a rate of 8 °C /min. Nitrogen was used as carrier gas (30 ml/min). USM was analysed on a Capillary HP6890 series, 1.5 m × 4 mm i.d. The injector and detector temperatures were set at 250 and 300 °C, respectively. The temperature was increased from 70 to 270 °C, at a rate of 10 °C /min. Nitrogen was used as the carrier gas (30 mL/min).

1, 1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity

A weighed amount of AEE was dissolved in methanol (100 μg/mL), screened for its free radical scavenging activity using the stable free radical DPPH, and then measured spectrophotometrically. The absorbance was measured at 517 nm and carried out in triplicate [18]. Radical scavenging activity was calculated by the following formula: DPPH scavenging effect (%) = [(A0 - A1)/A0) × 100], where A0 was the absorbance of the control reaction, and A1 was the absorbance of the sample [19]. The concentration of sample required to scavenge 50% of the DPPH was calculated from a graph plotted for the % inhibition against the concentration in μg/mL. Ascorbic acid was used as standard.

Hepatoprotective activity

Experimental animals

Eight-week-old male Wistar albino rats (200–220 g) were purchased from the National Institute of Ophthalmology, Egypt. The animals were kept in the animal house, October University for Modern Sciences and Arts (MSA), Egypt. All animals were kept in a pathogen-free facilities under standard laboratory conditions (temperature 25 ± 2 °C and 12 h light/12 h dark cycle) with free access to food and water. The animals were housed in groups of four in plastic cages with sawdust bedding. Experimental work was carried out in laboratories at MSA University, Egypt. Procedures involving animals and their care were in conformity with the institutional guidelines (Approval number of ethics committee, MSA University, EC 10 PG10/2011) and in compliance with national and international laws on the care and use of laboratory animals.

Experimental design

Two different doses of N. alba (100 and 200 mg/kg) were tested for their hepatoprotective effect against CCl4-induced hepatotoxicity. Doses and route of administration selection were according to previously published studies [12, 13]. Hepatotoxicity was induced by injection of a single intraperitoneal (I.P.) dose of CCl4 (0.5 ml/kg) [20]. A total of 40 rats were randomly divided into five groups ( = 8). Group I (Control): received vehicles. Group II (CCl4): received CCl4 (0.5 ml/kg; I.P.) once. Group III (N. alba low dose): received CCl4 (0.5 ml/kg; I.P.) + N. alba extract (100 mg/kg; P.O.) 24 h after CCl4 for 5 days. Group IV (N. alba high dose): received CCl4 (0.5 ml/kg; I.P.) + N. alba (200 mg/kg; P.O.) 24 h after CCl4 for 5 days. Group V (Silymarin): received CCl4 (0.5 ml/kg; I.P.) + silymarin (100 mg/kg; P.O.) 24 h after CCl4 for 5 days. Treatments were given at 10 a.m. Twenty-four hours after the last dose of treatments, blood samples were collected from the retro-orbital plexus. Serum was separated by centrifugation and stored at −80 °C. Rats were sacrificed; livers were excised, rinsed in ice-cold saline and blotted dry. Slices of liver tissue were fixed in 10% neutral formalin for histopathological examination and immunostaining of caspase-3. The rest of the liver tissue was weighed and homogenized in phosphate buffer saline to prepare 10% homogenate and stored at −80 °C.

Assessment of biochemical markers of hepatic injury

Biochemical parameters reflecting liver functions such as serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma glutamyl transpeptidase (GGT) and total bilirubin were estimated using commercially available kits, according to the manufacturer instructions (Spectrum, Egypt).

Assessment of oxidative stress in the liver

Liver malondialdehyde (MDA) and reduced glutathione (GSH) contents, catalase (CAT) and superoxide dismutase (SOD) activities and total antioxidant capacity (TAC) were assessed spectrophotometrically using commercial kits supplied by Bio-diagnostic (Bio-diagnostic, Egypt).

Estimation of inflammatory cytokine, TNF-α

TNF-α content was measured in liver homogenate using an ELISA kit (BioLegend ELISA MAX™ Deluxe kit; BioLegend, San Diego, CA, USA). The assay was performed according to the manufacturer’s protocol.

Histopathological examination of the liver

Liver specimens in 10% neutral formalin were embedded in paraffin and cut into 4 μm thick sections. Sections were stained with haematoxylin and eosin (H&E) and examined under a light microscope for histological changes.

Immunohistochemical staining for caspase-3 in liver

Caspase-3 expression in the liver was detected by immunostaining of sections prepared from formalin-fixed, paraffin-embedded livers using caspase-3 detection kits according to the manufacturer instructions. The intensity of caspase-3 immunostaining was assessed as follows: 0 – none, 1 – mild, 2 – moderate and 3 – strong. The Immunohistochemical histological score (H-score) was calculated by multiplying the intensity by the percentage of caspase-3 positive cells, creating a range of possible scores of 0–300 [21].

Statistical analysis

Data from animal work are expressed as the mean ± standard error of the mean (SEM). Comparisons between different groups were carried out by one-way analysis of variance (ANOVA) followed by the Tukey-Kramer test. The level of significance was set at p < 0.05. Graphpad software instat (version 2) was used to carry out statistical analysis.

Results

Phytochemical investigation

HRESI-MS/MS analysis of N. alba AEE

The chemical constituents in N. alba AEE were identified and characterized in both negative and positive ESI modes. The retention times and fragmentation patterns of the identified compounds are listed in Table 1. Compounds were tentatively identified based on matching their masses and fragmentation pattern with the literature information and ChemSpider. MS fragmentation interpretation is not discussed except when of special interest.
Table 1

Peak assignments and tentative identification of the major constituents in N. alba AEE by HRESI-MS/MSa in the positive and negative modes

Peak NumberTentatively Identified CompoundtRb (min.)[M-H]m/zd Negative Ionization MS/MSc [M + H]+m/zd Positive Ionization MS/MS
1HHDPe -hexoside1.85481.06 301.14 463.2 275.18483.08 465.14 437.07 309.07 263
2Epicatechin derivative2.94427.09 265.15 307.14 367.23 289.19 247.1 221.15
3Ellagitannin derivative3.59817.07 773 481 301.11 481.24 275.19 247.23819.09 801.2 481.13 463.05 337.14 319.14 303.12
4HHDP-galloyl-ellagic acid4.12773.09 301.17 729 471.27 275.24 247
5Ellagic acid4.44301.15 257.22 229.10 185.16303.1 275.03 257.1 247.04 229.13 165.02
6Isorhamnetin derivative5.38386.96 315 343.21 271.16 255.16 189.02 161.06
7Quercetin 3–O-acetyl hexoside12.73505.07 459.19 403.18 487.14 301.12 275.17 231.25 247.09 169.12507.09 489.14 447.14 405.14 387.03 303.18 205.14187.17
8Ellagic rhamnosyl hexoside13.27609.17 403.17 563.18 447.3 429.2 359.2 291.22 301.13 275.28 247.19611.18 593.30 551.30 533.27 449.30 389.21 343.21 303.22
9Lagerstannin A (Bis-HHDP-gluconic acid)13.40799.06 497.16 301.21 755.24 453.26801.08 463.15 765.11 783.17 481.15 337.12 303.15 277.10 247.15
10Brevifolin13.5247.02 203.11 bp 175.13249.6 207.05 232.12 221.12 187.08 159.04 131.04
11Phyllanthusiin U13.72924.11 301.01 622.2 604.24 905.22 451.19926.13 908.2 303.12 277.15 703.25 606.26
12Valoneic acid dilactone dimer13.81939.02 469.24 425.21 300.2941.02 453.15 922.27 621.2 470.99 407.19
133,4,8,9,10-Pentahydroxydibenzo[b,d]pyran-6-one14.13275.02 245.05 257.08 231.1 229.2 203.08 187.18277.03 235.23 221.17 183.17
14Luteolin14.34285.04 257.16 241.13 229.2 213.23 185.2 167.24
15Ellagitannin derivative14.45931.11 301.14 783.2933.03 873.05 915
16Methyl gallate14.56183.03 168.13 124.03 169.09185.33 167.07 153.03 104.96 129.07
17Ellagic acid hexoside15.54463.05 301.2 419.2 417.16 331.7 274.96 251.07 247.2465.05 303.09 447.13
18Catechin or epicatechin derivative15.83621.07 575.46 439.15 289.19 245.10 217.14
19Orientin16.3447.02 403.16 233.03 427.03 359.17 277.12 357.18 329.16 327.18 315.23 301.19 287.17 189.05
20Ellagitannin derivative16.63755.07 711.24 453.19 301.21 435.21 409.36 275 247.23
21Phyllanthusiin E17.04291.04 247.11 203.18293.03 247.11 275.06
22Ellagitannin derivative17.171153.09 799.17 755.21 453.16 409.24
23Phyllanthusiin B isomer18.05969.09 631.25 667.22 451.15 331.27 291.07
24Castalin derivative18.77967.07 631.14 451.2 571.19969.08 950.82 499.10 579.02 481.16 453.10 355.1 337.17
25HHDP-gluconic acid19.21497.06 463.20 453.24 301.07 291.18 275.18 257.25 247.23
26Ellagic acid-galloyl hexoside20.85613.05 451.13 425.26 569.22 509.16
27Phyllanthusiin B21.17969.09 633.26 923.18 951.26 667.26 ch301.24 451.30 275.18971.1 953.16 651.14 633.17 615.15 481.21 453.18 303.15 277.17
28Vescalagin or castalagin21.28933.06 613.20 301.15 631.2 273.14 915.21935.07 916.31 615.34 481.12 453.13 303.19 277.18
29Apigenin24.66269.03 223.01 179.07
30Phyllanthusiin C24.91925.10 605.29 301.08 623.23 905.15 633.08 453.09 291.18 273.06927.11 909.26 607.23 589.14 571.16 419.23 321.19 303.1 277.11
31Corilagin (Galloyl HHDP hexoside)25.14633.07 301.14 589.22 481.29 275.27 257.15635.08 443.11 617.23 573.16 355.11 254.15 191.12
32Pedunculagin (Bis HHDP-hexoside)25.77783.07 481.17 737.33 301.11 451.11785.08 767.15
33Castalin26.17631.06 301.20 299.12 451.18 271.05633.07 615.12
34Phyllanthusiin C derivative27.241217.12 925.56
35Lagerstannin C (Galloyl-HHDP-gluconic acid27.33649.1 603.26 605.27 631.23 469.18 441.17 451.26 301.14 247.19651.08 633.13 481.19 337.11
36Catechin or epicatechin28.29289.12 245.09 217.18291.42 247.1 272.03 235.09 219.07 191.07
37Lagerstannin B (flavogalloyl HHDP-gluconic acid)29.82949.11 647.25 905.25 629.24 477.24 333.21 301.15 275.2
38Granatin B(Galloyl-HHDP-DHHDP-hex)30.97951.08 605.26 649.21 301.15 631.23 907.21 952.19 497.23953.08 277.10 935.15 633.24 615.12 321.11 303.11
39Dehydrated tergallic C-glucoside31.4613.05 299.07 301.27 569.27 595.15 227.15615.06 453.14 387.09 313.15
40Cinnamic acid derv.31.5329.09 197.10 239.1 169.07331.13 299.09 313.19 272.12 236.09 151.04
41Phyllanthusin B derivative32.18981.59 969.23 933.23 613.24 481.26
42Valoneic acid dilactone32.47469 425.15 301.09
43Gallic acid derivative32.61198.62 169.06 153.14 125.21 117.06
44Ellagitannin derivative33.31907.08 605.19 863.09 587..23 561.23 301.14 275.11909.09 890.22 703.08 589.21 321.19 303.05 277.09
45Digalloyl ellagic acid33.62605.62 561.25 247.18 291.12 203.18 453.24 435.12 229.08607 315.05 589.27 565.23 549.25 505.27
46Castalgin derivative34.51965.09 631.22 301.03967.10 647.25 949.1 906.2 629.26 495.16 445.26 303.18 27.10
47Chebulagic acid34.79953.18 935.32, 907.22 649.28 605.1 631.28 301.22 291.24955.19 937.20 633.17 481.26 463.28 319.11 301.16 27.19
48Ellagic acid pentoside38.56433.04291.15 bp 405.17 301.18 275.23 247 229435.15417.19 bp 407.25 399.14 376.35 343.11 325.11 299.19 181.19
49Ellagic acid rhamnosyl39.07447.02 359.17 403.2 385.11 315.25 301.13 275.18448.98 413.09 405.24 331.08 277.1
50Geraniin40.40951.07 933.10 613.20 301.13 631.15
51Vescalagin derivative40.8965.09 613.2 933.19 301.09967.10 935.17 647.22 277.12
52Galloyl ellagic acid41.83453.04301.13 438.34 291.12 247.11 169.13 273.27455.08 437.13 394.98
53Gallic acid62.11169.01 125.11

Boldface digits reflects the base peak (100% abundance)

Fragment ions are listed in order of relative abundances

aHigh resolution liquid chromatography coupled with electrospray ionisation mass /mass spectometry

bRetention time

cMass/Mass spectrometry

dMass to charge ratio

eHexahydroxydiphenic acid

Peak assignments and tentative identification of the major constituents in N. alba AEE by HRESI-MS/MSa in the positive and negative modes Boldface digits reflects the base peak (100% abundance) Fragment ions are listed in order of relative abundances aHigh resolution liquid chromatography coupled with electrospray ionisation mass /mass spectometry bRetention time cMass/Mass spectrometry dMass to charge ratio eHexahydroxydiphenic acid Table 1 outlines 53 compounds, among them 42 hydrolysable tannins, three simple phenolic acids, and eight flavonoids were detected.

Estimation of USM and FAME

Nine hydrocarbons, two sterols and eleven fatty acids were identified in N. alba AEE. The percentage content of individual hydrocarbons and fatty acids are summarized in Tables 2 and 3. The percentage of identified hydrocarbons was estimated as 94.9% while the sterol content represented 5.03%. n-Tetracosane was determined as the major hydrocarbon (59.6%), n-tetratriacontane was detected as the second most abundant hydrocarbon (18.96%) while β-sitosterol was of significant percentage (3.5%). By comparison with the FAME standards, the percentage of the saturated fatty acid represents 49.3% where the major saturated fatty acid was palmitic acid (40.8%) while the major unsaturated fatty acids were linolenic acid (24.5%), linoleic acid (16.8%) and palmitoleic acid (8.5%).
Table 2

Unsaponifiable content in N. alba

CompoundPercent
n-tetradecane, C140.97
n-pentadecane, C150.84
n- hexadecane, C161.11
n-octadecane, C189.69
n-nonadecane, C191.13
n-tetracosane, C2459.59
n-octacosane, C282.67
n-tetratriacontane, C3018.96
Total hydrocarbons94.96
stigmasterol1.68
β-sitosterol3.35
Total sterols5.03
% Unidentified0.006
Table 3

Fatty acid composition (%) of N. alba

CompoundPercent
Octanoic (Caprylic) acid, C8:01.22
Decanoic (Capric) acid, C10:01.67
Tetradecanoic (Myristic) acid, C14:01.64
Hexadecanoic (Palmitic) acid, C16:040.84
Octadecanoic (Stearic) acid, C181.43
Eicosanoic (Archidic) acid, C202.51
∑SFAa 49.31
cis-9-Hexadecanoic(Palmitoleic) acid, C16:1ω 78.41
cis-9-Octadecanoic (Oleic) acid, C18:1ω91.04
∑MUFAb 9.45
cis,cis-9,12-Octadecadienoic (Linolenic) acid, C18:3, ω624.45
All cis-6,12,15-Octadecotrionic (Linoleic) acid, C18:2 ω616.78
∑PUFAsc 41.23
Total unsaturation50.68

aSaturated fatty acids

bMonounsaturated fatty acids

cPolyunsaturated fatty acids

Unsaponifiable content in N. alba Fatty acid composition (%) of N. alba aSaturated fatty acids bMonounsaturated fatty acids cPolyunsaturated fatty acids AEE showed strong DPPH scavenging activity as indicated by low IC50 (5.2 ± 0.3 μg/mL) and LC90 (9.1 ± 0.27 μg/mL) compared with ascorbic acid (12 ± 3.5 μg/mL).

Effect of N. alba on liver function parameters

Serum level of liver functions parameters; ALT, AST, GGT, ALP and total bilirubin were significantly increased in CCl4-intoxicated rats compared with normal level (P < 0.05; Table 4). Treatment with N. alba (100 and 200 mg/kg) resulted in significant decrease of ALT, AST, GGT, ALP and total bilirubin compared with CCl4-intoxicated rats in a dose dependant manner (P < 0.05; Table 4). Similarly, silymarin significantly improved the liver function parameters compared with CCl4 group (P < 0.05; Table 4).
Table 4

Effect of N.alba AEE on CCl4-induced changes in the liver function parameters in rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. ALT, AST, total bilirubin, GGT and ALP were measured

ParameterControlCCl4 N.alba extractSilymarin (100 mg/kg)
Low Dose (100 mg/kg)High Dose (200 mg/kg)
ALT (U/L)1 32.6 ± 3.188.1 ± 7.3a 58.4 ± 4b 41.9 ± 2.6b 38.1 ± 2.2b
AST (U/L)2 68.5 ± 3.5139 ± 8.3a 105.9 ± 4.1b 82.1 ± 6.1b 72.5 ± 4.7b
Total Bilirubin (mg/dl)0.2 ± 0.021.2 ± 0.1a 0.5 ± 0.03b 0.3 ± 0.03b 0.2 ± 0.02b
GGT (U/L)3 7.7 ± 0.635.9 ± 3.3a 20.8 ± 1.8b 12.9 ± 1.2b 12 ± 1.2b
ALP (U/L)4 278.5 ± 19.1496.5 ± 38.3a 414.7 ± 10.9b 346.6 ± 22.8b 294.2 ± 15.4b

Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05

1Alanine aminotransferase

2Aspartate aminotransferase

3Gamma glutamyl transpeptidase

4Alkaline phosphatase

Effect of N.alba AEE on CCl4-induced changes in the liver function parameters in rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. ALT, AST, total bilirubin, GGT and ALP were measured Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05 1Alanine aminotransferase 2Aspartate aminotransferase 3Gamma glutamyl transpeptidase 4Alkaline phosphatase

Effect of N. alba on oxidant status of the liver

Injection of CCl4 resulted in depletion of hepatic GSH content (59.7%), decrease in the activities of SOD and CAT (59.9 and 44.9%, respectively) and decline in TAC of the liver (65.7%) (P < 0.05; Figs. 1, 2, 3 and 4, respectively) compared with control group. Also, CCl4 significantly increased the liver lipid peroxidation product, MDA (249.1%) (P < 0.05; Fig. 5) compared with control group.
Fig. 1

The effect of N. alba AEE on the liver content of GSH in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. GSH was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05

Fig. 2

The effect of N. alba AEE on the liver SOD activity in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. SOD was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05

Fig. 3

The effect of N. alba AEE on the liver CAT activity in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. CAT was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05

Fig. 4

The effect of N. alba AEE on the liver TAC in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. TAC was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05

Fig. 5

The effect of N. alba AEE on the liver content of MDA in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. MDA was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05

The effect of N. alba AEE on the liver content of GSH in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. GSH was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05 The effect of N. alba AEE on the liver SOD activity in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. SOD was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05 The effect of N. alba AEE on the liver CAT activity in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. CAT was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05 The effect of N. alba AEE on the liver TAC in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. TAC was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05 The effect of N. alba AEE on the liver content of MDA in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. MDA was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05 Treatment of CCl4-intoxicated rats with N. alba (100 and 200 mg/kg) significantly increased the liver content of GSH (55.1 and 143.4%, respectively; P < 0.05; Fig. 1) compared with the CCl4 group. N. alba (100 and 200 mg/kg) significantly enhanced the enzymatic activities of both SOD (79.1 and 111.1%, respectively) and CAT (49.2 and 75.5%, respectively) (P < 0.05; Figs. 2 and 3, respectively) compared with the CCl4 group. Furthermore, TAC of the liver increased significantly (84.1 and 173.5%) by treatment with the N. alba (100 and 200 mg/kg, respectively) (P < 0.05; Fig. 4). On the other hand, treatment with N. alba (100 and 200 mg/kg) significantly decreased liver MDA content (38.2 and 67.6%), respectively, compared with the CCl4 group (P < 0.05; Fig. 5). Silymarin significantly increased the liver GSH content and TAC (151.7 and 97.3%, respectively) compared with the CCl4 group (P < 0.05; Figs. 1 and 4, respectively). The activities of SOD and CAT improved significantly (71 and 73.8%, respectively) by treatment with silymarin compared with the CCl4 group (P < 0.05; Figs. 2 and 3, respectively). The hepatic content of MDA decreased significantly (51.8.7%) compared with the CCl4 group (P < 0.05; Fig. 5).

Effect of N. alba on hepatic content of TNF-α

Hepatic content of TNF-α was significantly increased in CCl4 group compared with control rats. Treatment with N. alba (100 and 200 mg/kg) resulted in significant decrease of TNF-α in a dose dependant manner (Fig. 6). Silymarin significantly improved the hepatic content of TNF-α compared with CCl4 control group (Fig. 6).
Fig. 6

The effect of N. alba AEE on the liver content of TNF-α in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. TNF-α was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05

The effect of N. alba AEE on the liver content of TNF-α in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. TNF-α was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05

Histopathological examination of hepatic tissue

Livers excised from a control group showed a normal architecture of hepatocyte lobules with normal central and portal areas and normal hepatocytes (Fig. 7a). The liver samples from CCl4-intoxicated rats showed severe feathery degeneration and necrosis of hepatocytes (Fig. 7b). The portal area showed severe infiltration by lymphocytes and dilation of the central vein (Fig. 7c). Rats treated with low dose of N. alba (100 mg/kg; P.O.) for 5 days showed slight improvement of the histopathological features of the liver compared with the CCl4-intoxicated group (Fig. 7d). However, a high dose of N. alba (200 mg/kg; P.O.) and silymarin showed marked advances in the liver features and disappearance of the feathery degeneration of hepatocytes (Fig. 7e and f, respectively).
Fig. 7

Representative photomicrographs of histopathological examination of the liver. a Liver of control rats (b and c) Liver of rats intoxicated with CCl4 (0.5 ml/kg; P.O.) showing severe feathery degeneration of hepatocytes and lobular necrosis (B) and portal lymphocytic infiltration (c). d Liver of rats intoxicated with CCl4 and treated with N. alba (100 mg/kg; P.O.) showing slight improvement of feathery degeneration of hepatocytes. e Liver of rats intoxicated with CCl4 and treated with N. alba (200 mg/kg; P.O.) showed marked improvement of the histopathological features. f Liver of rats intoxicated with CCl4 and treated with silymarin (100 mg/kg; P.O.)

Representative photomicrographs of histopathological examination of the liver. a Liver of control rats (b and c) Liver of rats intoxicated with CCl4 (0.5 ml/kg; P.O.) showing severe feathery degeneration of hepatocytes and lobular necrosis (B) and portal lymphocytic infiltration (c). d Liver of rats intoxicated with CCl4 and treated with N. alba (100 mg/kg; P.O.) showing slight improvement of feathery degeneration of hepatocytes. e Liver of rats intoxicated with CCl4 and treated with N. alba (200 mg/kg; P.O.) showed marked improvement of the histopathological features. f Liver of rats intoxicated with CCl4 and treated with silymarin (100 mg/kg; P.O.)

Immunohistochemical staining of caspase-3

Liver excised from rats injected with CCl4 showed high caspase-3 expression (H score = 60; Fig. 8b) while, caspase-3 was negatively stained in the control group (H score = 0; Fig. 8a). Caspase-3 expression was decreased in CCl4-intoxicated rats treated with low dose of N. alba (100 mg/kg; H score = 20; Fig. 8c). CCl4-intoxicated rats received the high dose of N. alba as well as those received silymarin (Figs. 8d and e, respectively) showed negative staining for caspase-3 (H score = 0).
Fig. 8

Representative photomicrographs of immunohistochemical staining of caspase-3. a Liver of control rats, (b) Liver of rats intoxicated with CCl4 (0.5 ml/kg; P.O.), (c) Liver of rats intoxicated with CCl4 and treated with N. alba (100 mg/kg; P.O.), (d) Liver of rats intoxicated with CCl4 and treated with N. alba (200 mg/kg; P.O.), and (e) Liver of rats intoxicated with CCl4 and treated with silymarin (100 mg/kg; P.O.)

Representative photomicrographs of immunohistochemical staining of caspase-3. a Liver of control rats, (b) Liver of rats intoxicated with CCl4 (0.5 ml/kg; P.O.), (c) Liver of rats intoxicated with CCl4 and treated with N. alba (100 mg/kg; P.O.), (d) Liver of rats intoxicated with CCl4 and treated with N. alba (200 mg/kg; P.O.), and (e) Liver of rats intoxicated with CCl4 and treated with silymarin (100 mg/kg; P.O.)

Discussion

The hyphenated HPLC-MS technique is an important method used for identifying complex mixtures, especially the phenolics in the crude extracts or the fraction found in the plant, either by using standard compounds (cochromatography) or by comparing mass spectra obtained with the literature (tentative identification) [22]. A chemical characteristic of the order Nymphaeals, which includes the family Nymphaeaceae, is the occurrence of significant amounts of gallic acid and ellagic acid [23]. Ellagitannins attracted considerable attention because of their vast structural diversity and biological activity, including antioxidant, antiviral and antitumor activity [24, 25]. N. alba flowers and rhizomes are known for their high phenolic content [9-11], while leaves have never been well studied before. In this study, N. alba AEE was demonstrated as a very rich source of phenolic compounds where, hydrolysable tannins were the main polyphenols identified (forty-two compounds) distinguished by their characteristic fragment ion spectra yielding losses of galloyl (m/z 152), gallate (m/z 170) and esters of hexahydroxydiphenic acid (HHDP) residues (m/z 302), while the common loss of 44 amu indicates the presence of a free carboxylic group (COOH) [26, 27]. A total of twenty-six ellagitannins were tentatively identified. HHDP and a polyol and in some cases, gallic acid represent the majority of Nymphaea constituents. Peak 1 with a precursor ion at m/z 481 was identified as HHDP-glucose [28, 29]. The presence of HHDP was supported by the formation of m/z 301 in the negative ionization and 303 in the positive. Peak 31, shows m/z at 633 [M-H] and fragment ions at m/z 301 [M-H-152-180], 589 [M-H-44], 481 [M-H-152] was tentatively identified as a galloyl-HHDP-glucose (corilagin) isomer, agreeing with Fischer et al., [30] and Barros et al. [31]. Peak 32 shows m/z at 783 [M-H] and fragments at m/z 481 [M-H-302] and 301 [M-H-302-180] was identified as pedunculagin (Bis HHDP hexoside), the release of one HHDP molecule yielded 481 (peak 1) [32]. Two compounds with m/z 951 were detected at different retention time (Peak 38 and 50) which significantly differ in their fragmentation pattern, indicating the presence of isomeric structures which is common with ellagitannins. They were tentatively identified as granatin B and geraniin respectively [33, 34]. Three lagerstannins previously identified in Lagerstroemia speciosa were tentatively identified with the presence of gluconic acid. The common loss of 44 amu indicates the presence of a free carboxylic group [35]. Peak 35 shows m/z at 649 [M-H] and fragments at m/z 603 [M-H-44], 631 [M-H-18], 469 [M-H-180], 451 [M-H-44-152] and 301, which was identified as lagerstannin C (galloyl HHDP-gluconic acid). Peak 9 presents m/z at 799 [M-H] and fragments at m/z 755 [M-H-44], 497 [M-H-302] and 301 [M-H-302-196] and identified as lagerstannin A (Bis-HHDP-gluconic acid). Peak 37 shows m/z at 949 [M-H] and fragments at m/z 647 [M-H-302], 905 [M-H-44], 629 [M-H-44-152], 477 [M-H-302-170], 301 [M-H-302-170-176]. This peak was tentatively identified as Lagerstannin B (flavogalloyl-HHDP-gluconic acid) [30, 35]. Analysis of peaks 11, 27, 30 and 47, yielded intense product ions resulting from the loss of the HHDP and/or galloyl moiety. These peaks were tentatively identified as phyllanthusiin U, B, C and chebulagic acid detected with [M-H] at m/z 924, 969, 925 and 953, respectively and previously identified in Phyllanthus urinaria [36, 37]. Peak 28 with a pseudomolecular ion [M-H] at m/z 933.06 and fragment ions at m/z 915, 631, 451 and 301 were in agreement with the fragmentation pattern attributed to castalagin [38]. The release of one HHDP or ellagic acid moiety (302 Da) from castalagin generated Peak 33 with an [M-H] at m/z 631, showing the typical ellagic acid fragments at m/z 299 and m/z 271 and tentatively identified as castalin [28, 30]. The free ellagic acid was confirmed by its MS data and MS/MS fragmentation (peak 5), having m/z at 301 [M-H] in the negative mode and fragment ions at m/z 275, 257, 247, 229 and 185 [38]. Peaks 17, 48, 49 were tentatively identified as the glycosylated forms of ellagic acid with [M-H] at m/z 463, 433 and 447, respectively, showing the characteristic fragments of ellagic acid at m/z 301 and 275 in addition to the characteristic losses of a hexosyl, pentosyl and rhamnosyl residue, so, identified as ellagic acid hexoside, pentoside and rhamnoside respectively [30]. Peak 42 presents m/z at 469 [M-H] and a fragment at m/z 425, was tentatively identified as valoneic acid dilactone, a compound that often occurs in plants containing ellagitannins [39]. While peak 12 represented a dimer of valoneic acid dilactone with [M-H] at m/z 939 and main fragments at 469 and 425. Gallic acid and its derivatives were also tentatively identified where gallic acid appeared at peak 53 while peak 39 was tentatively identified as dehydrated tergallic acid with a pseudomolecular ion [M-H] at m/z 613 and fragment ions at m/z 569 [M-H-44], 461 [M-H-152] and 299 [M-H-152-162] [29, 30]. Flavonoids have also been detected where Peak 8 shows m/z at 505 [M-H] and daughter ion at m/z 301 [M-acetyl hexoside], was tentatively identified as quercetin 3-O-acetyl hexoside that was previously identified in the Nymphaea species [40]. Peak 31 has an [M-H] ion at m/z 289 and base peak at m/z 245 [M-H-44] was tentatively identified as catechin or epicatechin by Pérez-Magariño et al., [41]. Beside the phenolic content N. alba extract appeared also as rich source of fatty acid. Essential fatty acids (EFAs) such as linolenic, linoleic and oleic acids help to raise HDL cholesterol, supporting cardiovascular, reproductive and immune systems. N. alba extract contains several essential fatty acids as linoleic (16.78%) and linolenic acid (24.45%), and, therefore, has a potential nutritional value in agreement with Eromosele and Eromosele, [42]. In addition, N. alba provided a rich source of β-sitosterol (5%), which is reported to reverse the impairment of the glutathione/oxidized glutathione ratio induced by phorbol esters in macrophage cultures with the increase in manganese superoxide dismutase and glutathione peroxidase activities and the decrease in catalase activity [43]. Oxidative stress plays a crucial role in the development of the aging process and some chronic diseases [21]. The antioxidant potential of medicinal plants is attributed to the redox properties of the phenolic compounds and there are several reports that correlate the total phenolic content to the antioxidant activity [44-46]. N. alba was shown as a potent radical scavenger with low IC50 (5.2 ± 0.3 μg/mL) compared with ascorbic acid. This high radical scavenging activity suggests the ability of N. alba to reduce oxidative stress. In this study, the hepatoprotective effect of N. alba AEE against CCl4-induced hepatotoxicity was demonstrated for the first time in a dose-dependent manner. This protection was reflected biochemically by the significant improvement in serum levels of ALT, AST, ALP and GGT, indicating the ability of N. alba AEE to protect hepatocytes against the deleterious effects of CCl4. Furthermore, the significant decrease in the serum level of bilirubin indicated that bilirubin was taken up into the liver as a function of a healthy hepatocyte. The hepatoprotective effect of the extract against CCl4-intoxication was further supported by histopathological examinations which showed considerable improvement of the histopathological features of the liver with N. alba treatment. Silymarin is a unique flavonoid complex that has been reported to possess strong hepatoprotective properties and commonly used in experiments as a reference hepatoprotective substance [47]. Silymarin has a broad array of in vitro and in vivo activities such as anti-inflammatory, anti-apoptotic and antioxidant [48]. Our results showed that silymarin protects against CCl4-induced hepatotoxicity as reflected by the significant improvement in the liver enzymes and bilirubin as well as enhancement of the histopathological features of the liver which was in agreement to previous studies [46, 47]. The protective effect of a high dose of N. alba (200 mg/kg) against hepatotoxicity is comparable with the effect observed with silymarin (100 mg/kg) which indicates a strong hepatoprotective property of the high dose of N. alba. Caspase-3 is a protein that plays a vital role in apoptosis [49]. In the present study caspase-3 was extensively expressed in the liver excised from CCl4-intoxicated rats denoting the correlation between CCl4 induced hepatotoxicity and the high level of apoptosis of the hepatocytes as previously reported [50]. N. alba decreased the level of caspase-3 expression while the effect of the high dose of N. alba is similar to that of silymarin as both drugs showed negative staining for caspase-3. Consequently, the protective effect of N. alba extract against CCl4 is mediated, in part, by inhibition of apoptosis through caspase-3 dependant pathway. Oxidative stress has been shown to play a pivotal role in liver injury induced by CCl4 [51, 52]. Our results showed an obvious disturbance in oxidant-antioxidant balance of the liver subjected to CCl4 where injection of CCl4 increased the degree of lipid peroxidation as indicated by the significant increase in MDA level in the liver homogenate. Both non-enzymatic and enzymatic antioxidant defence mechanisms were deteriorated in CCl4-injected group. The oxidant-antioxidant status of the liver excised from CCl4-intoxicated rats was significantly improved by treatment with N. alba in a dose-dependent manner. These findings imply a profound in vivo antioxidant effect of N. alba. These results are consistent with the studies documented by Khan and Sultana, [12, 13], who reported that N. alba extract suppresses chemically-induced oxidative stress and kidney damage in Wistar rats. The strong antioxidant activity of silymarin has been documented previously in several studies [47, 48]. In the present study the antioxidant activity of the high dose of N. alba is comparable to the antioxidant activity of silymarin. TNF-α is an important inflammatory mediator that has been shown to be involved in diverse pathological processes and in our study, TNF-α is elevated significantly in the CCl4-intoxicated group, which was previously reported [51, 52]. Treatment with N. alba resulted in a significant decrease in the hepatic content of TNF-α, which is comparable, in its high dose, with silymarin. This result indicates a profound anti-inflammatory effect of N. alba which was in agreement with that reported in models of acetic acid-induced vascular permeability and cotton pellet-induced granuloma. In both models, N. alba exhibited an anti-inflammatory effect in a dose-dependent manner, which can be comparable with that of diclofenac sodium [6].

Conclusion

The results highlight the high phenolic content of N. alba leaves, denoting the predominance of hydrolysable tannins, mainly ellagitannins, in addition to the flavonoid content of major antioxidant activity. N. alba also appeared as a rich source of essential fatty acid with high nutritional value. Administration of N. alba extract remarkably protected against CCl4-induced hepatotoxicity to an extent comparable with silymarin. The suppression of oxidative stress and the inhibition of a crucial pro-inflammatory mediator such as TNF-α might be the possible mechanisms for the hepatoprotective activity of N. alba that help in restoration of the physiological and histological features of the liver. This preclinical study provides convincing evidence that N. alba extract can control inflammatory and oxidative stress-related liver diseases.
  35 in total

1.  Antihepatotoxic effect of Nymphaea stellata willd., against carbon tetrachloride-induced hepatic damage in albino rats.

Authors:  Manoj R Bhandarkar; Aqueel Khan
Journal:  J Ethnopharmacol       Date:  2004-03       Impact factor: 4.360

2.  Benzothiadiazole induces the accumulation of phenolics and improves resistance to powdery mildew in strawberries.

Authors:  Anne T Hukkanen; Harri I Kokko; Antony J Buchala; Gordon J McDougall; Derek Stewart; Sirpa O Kärenlampi; Reijo O Karjalainen
Journal:  J Agric Food Chem       Date:  2007-02-06       Impact factor: 5.279

Review 3.  Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.

Authors:  E Mariani; M C Polidori; A Cherubini; P Mecocci
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-23       Impact factor: 3.205

4.  beta-Sitosterol modulates antioxidant enzyme response in RAW 264.7 macrophages.

Authors:  Marta Vivancos; Juan J Moreno
Journal:  Free Radic Biol Med       Date:  2005-03-19       Impact factor: 7.376

5.  Identification and quantification of phenolic compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MS(n).

Authors:  Ulrike A Fischer; Reinhold Carle; Dietmar R Kammerer
Journal:  Food Chem       Date:  2011-01-11       Impact factor: 7.514

Review 6.  Flavonoid antioxidants.

Authors:  C Rice-Evans
Journal:  Curr Med Chem       Date:  2001-06       Impact factor: 4.530

7.  Fatty acid compositions of seed oils of Haematostaphis barteri and Ximenia americana.

Authors:  C O Eromosele; I C Eromosele
Journal:  Bioresour Technol       Date:  2002-05       Impact factor: 9.642

Review 8.  The importance of redox state in liver damage.

Authors:  Laura Cesaratto; Carlo Vascotto; Sebastian Calligaris; Gianluca Tell
Journal:  Ann Hepatol       Date:  2004 Jul-Sep       Impact factor: 2.400

9.  Protective effect of Pleurotus cornucopiae mushroom extract on carbon tetrachloride-induced hepatotoxicity.

Authors:  Bohi Khlood M El; Yoshiharu Hashimoto; Kaampwe Muzandu; Yoshinori Ikenaka; Zein Shaban Ibrahim; Akio Kazusaka; Shoichi Fujita; Mayumi Ishizuka
Journal:  Jpn J Vet Res       Date:  2009-08       Impact factor: 0.649

10.  Flavonoids and phenolic acids from Labisia pumila (Kacip Fatimah).

Authors:  Lee Suan Chua; Norliza Abdul Latiff; Sze Yean Lee; Chew Tin Lee; Mohamad Roji Sarmidi; Ramlan Abdul Aziz
Journal:  Food Chem       Date:  2011-02-01       Impact factor: 7.514

View more
  6 in total

1.  Exploring New Antioxidant and Mineral Compounds from Nymphaea alba Wild-Grown in Danube Delta Biosphere.

Authors:  Mihaela Cudalbeanu; Ioana Otilia Ghinea; Bianca Furdui; Durand Dah-Nouvlessounon; Robert Raclea; Teodor Costache; Iulia Elena Cucolea; Florentina Urlan; Rodica Mihaela Dinica
Journal:  Molecules       Date:  2018-05-23       Impact factor: 4.411

2.  Screening of NO Inhibitor Release Activity from Soft Coral Extracts Origin Palu Bay, Central Sulawesi, Indonesia.

Authors:  Wendy Alexander Tanod; Uun Yanuhar; Masteria Yunovilsa Putra; Yenny Risjani
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2019

3.  Antilisterial Effect of Rosa damascena and Nymphaea alba in Mus musculus.

Authors:  Rida Batool; Asma Kalsoom; Iqra Akbar; Najma Arshad; Nazia Jamil
Journal:  Biomed Res Int       Date:  2018-01-23       Impact factor: 3.411

4.  High Resolution Mass Spectroscopy-Based Secondary Metabolite Profiling of Nymphaea nouchali (Burm. f) Stem Attenuates Oxidative Stress via Regulation of MAPK/Nrf2/HO-1/ROS Pathway.

Authors:  Md Badrul Alam; Marufa Naznin; Syful Islam; Fanar Hamad Alshammari; Hee-Jeong Choi; Bo-Rim Song; Sunghwan Kim; Sang-Han Lee
Journal:  Antioxidants (Basel)       Date:  2021-05-03

Review 5.  Advantages of Hyaluronic Acid and Its Combination with Other Bioactive Ingredients in Cosmeceuticals.

Authors:  Anca Maria Juncan; Dana Georgiana Moisă; Antonello Santini; Claudiu Morgovan; Luca-Liviu Rus; Andreea Loredana Vonica-Țincu; Felicia Loghin
Journal:  Molecules       Date:  2021-07-22       Impact factor: 4.411

6.  Immunomodulatory Efficacy-Mediated Anti-HCV and Anti-HBV Potential of Kefir Grains; Unveiling the In Vitro Antibacterial, Antifungal, and Wound Healing Activities.

Authors:  Sawsan Abd Ellatif; Elsayed S Abdel Razik; Marwa M Abu-Serie; Ahmed Mahfouz; Abdullah F Shater; Fayez M Saleh; Mohamed M Hassan; Walaa F Alsanie; Abdullah Altalhi; Ghadir E Daigham; Amira Y Mahfouz
Journal:  Molecules       Date:  2022-03-21       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.